Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion

Acta Ophthalmologica

Volumn 92, Issue 3, 2014, Pages

  Sohn, Hee Jin ^a   Han, Dae Heon ^b   Lee, Dae Yeong ^b   Nam, Dong Heun ^b  

^a Hong Ik University   (South Korea)

^b Gachon University   (South Korea)

Author keywords

bevacizumab; branch retinal vein occlusion; cytokines; macular oedema; triamcinolone; vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR AA; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; GLUCOCORTICOID; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CATARACT EXTRACTION; CENTRAL FOVEAL THICKNESS; CLINICAL ARTICLE; CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; ENDOPHTHALMITIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; RETINA MACULA EDEMA; RETINAL THICKNESS; THROMBOEMBOLISM; VISUAL ACUITY; VITREOUS HEMORRHAGE; ANTAGONISTS AND INHIBITORS; CHEMISTRY; COMPLICATION; DOSE RESPONSE; FOLLOW UP; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; METABOLISM; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; AQUEOUS HUMOR; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINA; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84899427484     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12219     Document Type: Article

References (21)

1. Byun YJ, Roh MI, Lee SC, &, Koh HJ, (2010): Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 248: 963-971.
2. Cekiç O, Cakbox drawings light down and leftr M, Yazbox drawings light down and leftcbox drawings light down and left AT, Alagöz N, Bozkurt E, &, Faruk Ybox drawings light down and leftlmaz O, (2010): A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Curr Eye Res 35: 925-929.
3. Ehrlich R, Ciulla TA, Moss AM, &, Harris A, (2010): Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow. Graefes Arch Clin Exp Ophthalmol 248: 375-380.
4. Funk M, Kriechbaum K, Prager F, Benesch T, Georgopoulos M, Zlabinger GJ, &, Schmidt-Erfurth U, (2009): Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci 50: 1025-1032.
5. Guthoff R, Meigen T, Hennemann K, &, Schrader W, (2010): Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis. Ophthalmologica 224: 319-324.
6. Kaneda S, Miyazaki D, Sasaki SI, et al., (2011): Multivariate analyses of inflammatory cytokines in eyes with branch retinal vein occlusion: relationships to bevacizumab treatment. Invest Ophthalmol Vis Sci 52: 2982-2988.
7. Kelkar AS, Sayyad MG, &, Kelkar JA, (2009): Comparison of single injection of intravitreal triamcinolone versus single injection of intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusions with regard to changes in best corrected visual acuity and central macular thickness in the short term. Indian J Ophthalmol 57: 243-344.
8. Kunikata H, Shimura M, Nakazawa T, Sonoda KH, Yoshimura T, Ishibashi T, &, Nishida K, (2012): Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular edema associated with branch retinal vein occlusion. Acta Ophthalmol 90: 162-167.
9. Lim JW, (2010): Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion. Ophthalmologica 225: 150-154.
10. Maier R, Weger M, Haller-Schober EM, et al., (2008): Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients. Mol Vis 14: 637-643.
11. Nirmal K, (2010): Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol 4: 809-816.
12. Noma H, Funatsu H, Yamasaki M, et al., (2005): Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140: 256-261.
13. Noma H, Funatsu H, Yamasaki M, et al., (2008): Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) 22: 42-48.
14. Noma H, Funatsu H, Mimura T, &, Shimada K, (2010): Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study. J Inflamm (Lond) 7: 44.
15. Park SP, &, Ahn JK, (2008): Changes of aqueous vascular endothelial growth factor and interleukin-6 after intravitreal triamcinolone for branch retinal vein occlusion. Clin Experiment Ophthalmol 36: 831-835.
16. Park SP, &, Ahn JK, (2009): Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. Clin Experiment Ophthalmol 37: 490-495.
17. Ross R, (1999): Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
18. Takahashi H, Numasaki M, Lotze MT, &, Sasaki H, (2005): Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunol Lett 98: 189-193.
19. Tedgui A, &, Mallat Z, (2006): Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86: 515-581.
20. Yamasaki M, Noma H, Funatsu H, Minamoto A, Mimura T, Shimada K, Yamashita H, &, Kiuchi Y, (2009): Changes in foveal thickness after vitrectomy for macular edema with branch retinal vein occlusion and intravitreal vascular endothelial growth factor. Int Ophthalmol 29: 161-167.
21. Yoshimura T, Sonoda KH, Sugahara M, et al., (2009): Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS ONE 4: e8158.